The only thing irrelevant is the post I’m replying to. A liquidation process is a liquidation there is no difference. The CCAA and subsequent liquidation of all assets was it. Why would there be a need for anything once the liquidation ended with FKA BioAmber leaving all of its creditors impaired due to being paid a total of $4.34 mil from LCYB against $100 plus mil in liabilities ?
All that’s left is an asset less voided dead shell with a bunch of worthless shares and upwards of $100 mil of bad debt attached to it?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.